Active substanceHuman albuminHuman albumin
Similar drugsTo uncover
  • Albionin 20%
    solution d / infusion 
    Biotest Pharma GmbH     Germany
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Albumen
    solution d / infusion 
  • Human serum albumin
    solution d / infusion 
    Green Cross Corporation     The Republic of Korea
  • Human albumin
    solution d / infusion 
    Baxter AG     Austria
  • Human albumin
    solution d / infusion 
  • Alburex®
    solution d / infusion 
    CESEL Behring AG     Switzerland
  • Zenalb®-20
    solution d / infusion 
  • Zenalb-4,5
    solution d / infusion 
  • Plazbumin®-20
    solution d / infusion 
  • Uman albumin
    solution d / infusion 
    Kedrion SpA     Italy
  • Dosage form: & nbspsolution for infusions
    Composition:

    Active substance: albumin - 100 g,

    Excipients:

    sodium caprylate - 3 g,

    sodium chloride - 6.5 grams,

    water for injection - 1 liter.

    Description:Transparent liquid is yellow, a greenish shade is allowed.
    Pharmacotherapeutic group:Plasmasuberant
    ATX: & nbsp

    B.05.A.A.01   Albumen

    Pharmacodynamics:

    Plasma-reducing agent obtained by fractionating human plasma. It replenishes the deficiency of plasma albumin, supports the colloid-osmotic (oncotic) blood pressure, rapidly increases blood pressure and circulating blood volume, increases the transition and promotes retention of tissue fluid in the bloodstream, increases the protein supply reserves of tissues and organs. It has detoxification properties.

    Indications:

    Shock (traumatic, operational and toxic); burns accompanied by dehydration and "thickening" of blood; hypoproteinemia, hypoalbuminemia, developing with alimentary dystrophy, nephrotic syndrome, glomerulonephritis, cirrhosis, long-term ongoing purulent processes, lesions of the gastrointestinal tract with impaired absorption or patency.

    Contraindications:

    Hypersensitivity, severe anemia, chronic heart failure II-III stage, hypervolemia, pulmonary edema.

    Carefully:Arterial hypertension, renal failure, thrombosis, continuing internal bleeding, chronic heart failure of stage 1.
    Pregnancy and lactation:

    In pregnancy, the use of human albumin is possible only in cases of extreme necessity.

    Data on the safety of human albumin use during lactation are not available.

    Dosing and Administration:10% albumin solution is administered intravenously drip, at a rate of 50-60 cap / min, single dose of 200 ml. The dose is set individually depending on the indications and clinical picture or 1 - 2 ml / kg of 10% solution daily until the effect is achieved.
    Side effects:

    Allergic reactions, hives, hyperthermia, pain in the lumbar region.

    Overdose:

    No data.

    Interaction:

    In practice, drugs that interact with albumin are unknown.

    Special instructions:The albumin solution should be clear and free of sediment and sediment.

    Patients with dehydration should be provided with sufficient fluid intake before administration of albumin.

    Effect on the ability to drive transp. cf. and fur:

    The drug does not reduce the ability to drive.

    Form release / dosage:Solution for infusions 10%.
    Packaging:

    For 50, 100, 200 and 400 ml in bottles of blood glass transfusion preparations with a capacity of 5,100, 250, 450 and 500 ml.

    Solution for infusions 10% in ampoules of 10 ml.

    Each bottle and ampoules of 5 or 10 pieces are placed in boxes of cardboard together with instructions for use. An ampoule knife is placed in a box with ampoules.
    Storage conditions:

    At a temperature of 2 to 10 ° C out of the reach of children.

    Special precautions when destroying an unused preparation are not available.

    Shelf life:5 years. Do not use after the time specified on the package.
    Terms of leave from pharmacies:On prescription
    Registration number:LS-000118
    Date of registration:12.05.2010 / 03.06.2013
    Expiration Date:Unlimited
    The owner of the registration certificate:SAMARA REGION OF TRANSFUSION OF BLOOD SAMARA REGION OF TRANSFUSION OF BLOOD Russia
    Manufacturer: & nbsp
    Information update date: & nbsp15.07.2017
    Illustrated instructions
      Instructions
      Up